 |
|
Magnets for Patients With Heel Pain—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: In response to Dr Weintraub, plantar fasciitis is a clinical diagnosis, not a laboratory diagnosis. Magnetic resonance imaging, radiographs, and nerve conduction studies have not been validated in the literature as being diagnostic for plantar fasciitis and they are not used routinely as such in clinical practice.
In contrast with Weintraub's claims, our study did not limit "magnetic application" to only 4 hours per day, 4 days per week. Rather, the protocol suggested this as minimum use. Daily diary responses indicated that the participants typically used the insoles 6 to 7 days per week for 9 to 10 hours per day.
The consideration of magnet placement within the insole is a valid concern, although one of uncertain clinical significance. There would have been some variability between participants as to the physical proximity of the magnetic foil to the plantar fascia. However, there was also likely some variability between . . . [Full Text of this Article]
Mark H. Winemiller, MD;
Edward R. Laskowski, MD
Department of Physical Medicine and Rehabilitation
Mayo Clinic College of Medicine
Rochester, Minn
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Magnets for Patients With Heel Pain
Michael I. Weintraub
JAMA. 2004;291(1):43-44.
EXTRACT
| FULL TEXT
Effect of Magnetic vs Sham-Magnetic Insoles on Plantar Heel Pain: A Randomized Controlled Trial
Mark H. Winemiller, Robert G. Billow, Edward R. Laskowski, and W. Scott Harmsen
JAMA. 2003;290(11):1474-1478.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project
Bartholomew et al.
Clin Trials 2009;6:329-343.
ABSTRACT
Comparative effectiveness research: Relevance and applications to pharmacy
Schumock and Pickard
Am J Health Syst Pharm 2009;66:1278-1286.
ABSTRACT
| FULL TEXT
Beyond the Randomized Clinical Trial: The Role of Effectiveness Studies in Evaluating Cardiovascular Therapies
Nallamothu et al.
Circulation 2008;118:1294-1303.
FULL TEXT
Changes in Antihypertensive Prescribing During US Outpatient Visits for Uncomplicated Hypertension Between 1993 and 2004
Ma et al.
Hypertension 2006;48:846-852.
ABSTRACT
| FULL TEXT
How Many "Me-Too" Drugs Are Enough? The Case of Physician Preferences for Specific Statins
Austin et al.
The Annals of Pharmacotherapy 2006;40:1047-1051.
ABSTRACT
| FULL TEXT
|
